Similar articles for PMID: 20679474

Year	Number of Results
1984	1
1994	1
1997	1
1998	3
1999	2
2000	3
2001	4
2002	1
2003	1
2004	2
2005	3
2006	1
2007	3
2008	1
2009	2
2010	6
2011	8
2012	7
2013	3
2014	8
2015	7
2016	7
2017	7
2018	10
2019	8
2020	9
2021	2
2022	1
2024	0

1

Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.

Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA Jr. Domsic RT, et al. Ann Rheum Dis. 2011 Jan;70(1):104-9. doi: 10.1136/ard.2009.127621. Epub 2010 Aug 2. Ann Rheum Dis. 2011. PMID: 20679474 Free PMC article.

2

Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.

Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA Jr. Perera A, et al. Arthritis Rheum. 2007 Aug;56(8):2740-6. doi: 10.1002/art.22747. Arthritis Rheum. 2007. PMID: 17665460 Free article.

3

Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis.

Ostojic P, Damjanov N. Ostojic P, et al. Rheumatol Int. 2011 Aug;31(8):1051-4. doi: 10.1007/s00296-010-1398-1. Epub 2010 Mar 23. Rheumatol Int. 2011. PMID: 20309694 Clinical Trial.

4

Severe organ involvement in systemic sclerosis with diffuse scleroderma.

Steen VD, Medsger TA Jr. Steen VD, et al. Arthritis Rheum. 2000 Nov;43(11):2437-44. doi: 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U. Arthritis Rheum. 2000. PMID: 11083266 Free article.

5

Rapid skin thickness progression rate is associated with high incidence rate of cardiopulmonary complications in patients with early diffuse cutaneous systemic sclerosis: inception cohort study.

Wangkaew S, Thongwitokomarn H, Prasertwittayakij N, Euathrongchit J. Wangkaew S, et al. Clin Exp Rheumatol. 2020 May-Jun;38 Suppl 125(3):98-105. Epub 2020 Aug 26. Clin Exp Rheumatol. 2020. PMID: 32865165 Free article.

6

Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.

Nevskaya T, Zheng B, Baxter CA, Ramey DR, Pope JE, Baron M; for Canadian Scleroderma Research Group. Nevskaya T, et al. Rheumatology (Oxford). 2020 Jul 1;59(7):1715-1724. doi: 10.1093/rheumatology/kez529. Rheumatology (Oxford). 2020. PMID: 31774531

7

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.

Wu W, Jordan S, Graf N, de Oliveira Pena J, Curram J, Allanore Y, Matucci-Cerinic M, Pope JE, Denton CP, Khanna D, Distler O; EUSTAR Collaborators. Wu W, et al. Ann Rheum Dis. 2019 May;78(5):648-656. doi: 10.1136/annrheumdis-2018-213455. Epub 2019 Mar 9. Ann Rheum Dis. 2019. PMID: 30852552 Free PMC article.

8

Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.

Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, Denton CP. Shand L, et al. Arthritis Rheum. 2007 Jul;56(7):2422-31. doi: 10.1002/art.22721. Arthritis Rheum. 2007. PMID: 17599771 Free article.

9

Clinical approach to scleroderma.

White B. White B. Semin Cutan Med Surg. 1998 Sep;17(3):213-8. doi: 10.1016/s1085-5629(98)80016-3. Semin Cutan Med Surg. 1998. PMID: 9759679

10

Determinants of morbidity and mortality of systemic sclerosis in Canada.

Al-Dhaher FF, Pope JE, Ouimet JM. Al-Dhaher FF, et al. Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15. Semin Arthritis Rheum. 2010. PMID: 18706680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year